Literature DB >> 27518468

Genetically Determined Chronic Pancreatitis but not Alcoholic Pancreatitis Is a Strong Risk Factor for Pancreatic Cancer.

Shallu Midha1, Vishnubhatla Sreenivas, Madhulika Kabra, Tushar Kanti Chattopadhyay, Yogendra Kumar Joshi, Pramod Kumar Garg.   

Abstract

OBJECTIVE: To study if chronic pancreatitis (CP) is a risk factor for pancreatic cancer.
METHODS: Through a cohort and a case-control study design, CP and other important risk factors including smoking, diabetes, alcohol, obesity, and genetic mutations were studied for their association with pancreatic cancer.
RESULTS: In the cohort study, 402 patients with CP were included. During 3967.74 person-years of exposure, 5 of the 402 patients (4 idiopathic CP, 1 hereditary CP) developed pancreatic cancer after 16.60 ± 3.51 years of CP. The standardized incidence ratio was 121. In the case-control study, 249 pancreatic cancer patients and 1000 healthy controls were included. Of the 249 patients with pancreatic cancer, 24 had underlying idiopathic CP, and none had alcoholic pancreatitis. SPINK1 gene mutation was present in 16 of 26 patients with idiopathic CP who had pancreatic cancer. Multivariable analysis showed CP (odds ratio [OR], 97.67; 95% confidence interval [CI], 12.69-751.36), diabetes (>4 years duration) (OR, 3.05; 95% CI, 1.79-5.18), smoking (OR, 1.93; 95% CI, 1.38-2.69) as significant risk factors for pancreatic cancer. The population attributable risk was 9.41, 9.06, and 9.50 for diabetes, CP, and smoking, respectively.
CONCLUSIONS: Genetically determined CP but not alcoholic CP is a strong risk factor for pancreatic cancer.

Entities:  

Mesh:

Year:  2016        PMID: 27518468     DOI: 10.1097/MPA.0000000000000684

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  15 in total

1.  An Evaluation of Factors Associated With Pathogenic PRSS1, SPINK1, CTFR, and/or CTRC Genetic Variants in Patients With Idiopathic Pancreatitis.

Authors:  Niloofar Y Jalaly; Robert A Moran; Farshid Fargahi; Mouen A Khashab; Ayesha Kamal; Anne Marie Lennon; Christi Walsh; Martin A Makary; David C Whitcomb; Dhiraj Yadav; Liudmila Cebotaru; Vikesh K Singh
Journal:  Am J Gastroenterol       Date:  2017-04-25       Impact factor: 10.864

Review 2.  Total pancreatectomy for recurrent acute and chronic pancreatitis: a critical review of patient selection criteria.

Authors:  Mahya Faghih; Francisco Garcia Gonzalez; Martin A Makary; Vikesh K Singh
Journal:  Curr Opin Gastroenterol       Date:  2017-09       Impact factor: 3.287

3.  Germline Variants and Risk for Pancreatic Cancer: A Systematic Review and Emerging Concepts.

Authors:  Wei Zhan; Celeste A Shelton; Phil J Greer; Randall E Brand; David C Whitcomb
Journal:  Pancreas       Date:  2018-09       Impact factor: 3.327

4.  Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in BRCA1 and BRCA2.

Authors:  Amethyst Saldia; Sara H Olson; Pamela Nunes; Xiaolin Liang; Marguerite L Samson; Erin Salo-Mullen; Vanessa Marcell; Zsofia K Stadler; Peter J Allen; Kenneth Offit; Robert C Kurtz
Journal:  Cancer Prev Res (Phila)       Date:  2019-07-23

5.  Prevalence of primary painless chronic pancreatitis: A systematic review and meta-analysis.

Authors:  Furqan A Bhullar; Mahya Faghih; Venkata S Akshintala; Ahmed I Ahmed; Katie Lobner; Elham Afghani; Anna E Phillips; Phil A Hart; Mitchell L Ramsey; Benjamin L Bick; Louise Kuhlmann; Asbjørn M Drewes; Dhiraj Yadav; Søren S Olesen; Vikesh K Singh
Journal:  Pancreatology       Date:  2021-11-18       Impact factor: 3.996

6.  Hereditary Pancreatitis in the United States: Survival and Rates of Pancreatic Cancer.

Authors:  Celeste A Shelton; Chandraprakash Umapathy; Kimberly Stello; Dhiraj Yadav; David C Whitcomb
Journal:  Am J Gastroenterol       Date:  2018-07-18       Impact factor: 10.864

Review 7.  The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go.

Authors:  Elizabeth D Thompson; Nicholas J Roberts; Laura D Wood; James R Eshleman; Michael G Goggins; Scott E Kern; Alison P Klein; Ralph H Hruban
Journal:  Mod Pathol       Date:  2020-07-23       Impact factor: 7.842

8.  Upregulated exosomic miR‑23b‑3p plays regulatory roles in the progression of pancreatic cancer.

Authors:  Dayang Chen; Xiongbo Wu; Min Xia; Fang Wu; Junli Ding; Yang Jiao; Qiang Zhan; Fangmei An
Journal:  Oncol Rep       Date:  2017-08-24       Impact factor: 3.906

Review 9.  Systematic review of pancreatic cancer epidemiology in Asia-Pacific Region: major patterns in GLOBACON 2012.

Authors:  Mohamad Amin Pourhoseingholi; Sara Ashtari; Nastaran Hajizadeh; Zeinab Fazeli; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017

10.  High Prevalence of Serine Protease Inhibitor Kazal Type 1 Gene Variations Detected by Whole Gene Sequencing in Patients with Fibrocalculous Pancreatic Diabetes.

Authors:  Anish Kolly; C Shivaprasad; Annie A Pulikkal; Sridevi Atluri; Vijaya Sarathi; C S Dwarakanath
Journal:  Indian J Endocrinol Metab       Date:  2017 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.